Predictors of treatment duration in patients with mHSPC treated with ENZA: A post hoc analysis of ARCHES. Prior analyses from the phase 3 ARCHES trial demonstrated significant improvements in ...
Genomic and transcriptomic correlates of deep PSA response in patients with mHSPC. Despite major advances in combination treatment strategies for metastatic hormone-sensitive prostate cancer (mHSPC), ...
A randomized, double-blind, active-control, multicenter phase 3 trial of casdatifan and cabozantinib versus placebo and cabozantinib in patients with advanced clear cell RCC. Treatment options remain ...
(UroToday.com) The 2026 American Society of Clinical Oncology Genitourinary (ASCO) Annual Meeting held in Chicago, IL, will host the Prostate, Testicular, and Penile Cancer – Posters Session. Dr.
(UroToday.com) The 2026 American Society of Clinical Oncology Genitourinary (ASCO) Annual Meeting, held in Chicago, IL, will host the Kidney and Bladder Cancer - Posters. Dr. Joaquim Bellmunt will ...
(UroToday.com) The 2026 American Society of Clinical Oncology Genitourinary (ASCO) Annual Meeting, held in Chicago, IL, will host the Prostate, Testicular, and Penile Cancer – Posters Session. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results